Explainable Machine Learning Models for Alzheimer's Diagnosis Using Routine and Low-Cost Clinical Data
Medrxiv : the Preprint Server for Health Sciences
|July 30, 2026
Summary
This study developed an explainable deep learning model for Alzheimer's Disease (AD) diagnosis using routine clinical data, achieving high accuracy and outperforming clinicians. Early and cost-effective AD detection is now more feasible.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Diagnostics
Background:
- Alzheimer's Disease (AD) is a growing global health concern, characterized by progressive neurodegeneration leading to cognitive decline.
- Current diagnostic methods face challenges with long waiting times and high costs, necessitating faster, more accessible solutions.
- There is a clear need for cost-effective and rapid diagnostic techniques for Alzheimer's Disease.
Purpose of the Study:
- To develop an explainable deep learning model for diagnosing Alzheimer's Disease (AD).
- To utilize routine, low-cost clinical data for AD diagnosis, including demographics, patient history, and automatically acquirable neuropsychological test results.
- To create classification models capable of distinguishing Alzheimer's Disease as the cause of cognitive impairment.
Main Methods:
- Analysis of a large dataset (167,364 observations, 1,024 features) from the National Alzheimer's Coordinating Center.
- Development and application of an explainable deep learning model (deep neural network).
- Implementation of a Light Gradient Boosting Machine for comparative analysis.
Main Results:
- The deep neural network achieved 90% accuracy and a 0.96 ROC-AUC for AD diagnosis.
- The Light Gradient Boosting Machine model reached 90% accuracy with a 0.97 ROC-AUC.
- Diagnostic performance was comparable, and in some aspects superior, to that of clinicians under similar data constraints.
Conclusions:
- Explainable deep learning models can effectively diagnose Alzheimer's Disease using standard clinical data.
- The developed models offer a cost-effective and efficient alternative for early AD detection.
- This approach has the potential to significantly improve diagnostic accessibility and timeliness for Alzheimer's Disease.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

